Pay in 4 interest-free payments of $5.65 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
N., Harvey, B
In our study, FOXO4-DRI was found to effectively promote apoptosis in senescent cells by blocking the FOXO4-P53 interaction and facilitating P53 phosphorylation
The mechanism is fundamentally different
Cagrilintide is the first long-acting amylin analog to reach Phase 3 trials, with fatty acid acylation enabling once-weekly dosing compared to the three-times-daily dosing required by the older amylin analog pramlintide
doi: 10.21873/invivo.11308 120
US$ 29.41
US$ 27.93
US$ 22.36
US$ 20.14
